Pharmacy Usual Items - Northern Europe

  • Northern Europe
  • Revenue in the Pharmacy Usual Items market is projected to reach US$1.00bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.47%, resulting in a market volume of US$1.13bn by 2029.
  • In global comparison, most revenue will be generated in China (US$48,050.00m in 2024).
  • In relation to total population figures, per person revenues of US$29.42 are generated in 2024.

Key regions: Japan, France, China, Australia, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Pharmacy Usual Items market in Northern Europe has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in Northern Europe have played a crucial role in driving the growth of the Pharmacy Usual Items market. Consumers in this region have shown a strong preference for convenience and accessibility when it comes to purchasing their everyday pharmacy items. As a result, there has been an increased demand for online shopping and home delivery services, allowing customers to easily access and purchase their usual items from the comfort of their own homes. This shift in consumer behavior has led to the emergence of online pharmacies and the expansion of existing e-commerce platforms in the region. Trends in the market have also contributed to the growth of the Pharmacy Usual Items market in Northern Europe. One notable trend is the increasing focus on health and wellness among consumers. There has been a growing awareness of the importance of self-care and preventive healthcare, leading to an increased demand for products such as vitamins, supplements, and personal care items. Additionally, there has been a rising interest in natural and organic products, as consumers become more conscious of the ingredients and materials used in the products they use. This trend has prompted pharmacies in Northern Europe to expand their product offerings to cater to these evolving consumer preferences. Local special circumstances have further propelled the growth of the Pharmacy Usual Items market in Northern Europe. The region's aging population has created a higher demand for healthcare products and services, including pharmacy usual items. As the population continues to age, the demand for products such as prescription medications, mobility aids, and medical devices is expected to increase. Furthermore, the presence of a well-established healthcare system and universal healthcare coverage in many Northern European countries has contributed to the accessibility and affordability of pharmacy usual items, further driving market growth. Underlying macroeconomic factors have also played a role in the development of the Pharmacy Usual Items market in Northern Europe. The region's stable and prosperous economies have provided consumers with higher disposable incomes, allowing them to spend more on healthcare and wellness products. Additionally, the increasing focus on preventive healthcare and self-care has led to a shift in consumer spending patterns, with a greater proportion of household budgets allocated to pharmacy usual items. This favorable economic environment has created a conducive market for the growth of the Pharmacy Usual Items market in Northern Europe. In conclusion, the Pharmacy Usual Items market in Northern Europe has experienced significant growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The region's focus on convenience and accessibility, increasing interest in health and wellness, aging population, well-established healthcare system, and favorable economic environment have all contributed to the development of this market. As these factors continue to evolve, the Pharmacy Usual Items market in Northern Europe is expected to further expand in the coming years.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)